Central African Republic vs Lebanon: Immunization, Hib3
Central African Republic
42.0%
in 2024
Lebanon
51.0%
in 2024
Central African Republic rank
188th
Lebanon rank
186th
Immunization, Hib3 over time
- Central African Republic
- Lebanon
How they compare
Lebanon currently reports 51.0% against 42.0% in Central African Republic, a difference of 9.0%.
That makes Lebanon's figure about 1.2 times Central African Republic's.
Across all 16 years both countries report, Lebanon has been ahead every year.
Central African Republic ranks 188th and Lebanon ranks 186th of 191 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.0% | 82.0% | 40.0% | Lebanon |
| 2010s | 41.2% | 84.5% | 43.3% | Lebanon |
| 2020s | 37.4% | 63.4% | 26.0% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Central African Republic or Lebanon?
- Lebanon, at 51.0% against 42.0% in Central African Republic as of 2024.
- What is the difference in immunization, hib3 between Central African Republic and Lebanon?
- 9.0%, with Lebanon ahead.
- How many years of comparable data are there for Central African Republic and Lebanon?
- 16 years are reported by both, from 2009 to 2024.
- How do Central African Republic and Lebanon rank globally for immunization, hib3?
- Central African Republic ranks 188th and Lebanon ranks 186th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.